Triple layered QSAR Studies on Substituted 1,2,4-Trioxanes as potential antimalarial agents: Superiority of the Quantitative Pharmacophore-Based Alignment, Over Common Substructure based Alignment
Abstract
The present study reports the utilization of three approaches viz Pharmacophore, CoMFA, CoMSIA and HQSAR studies to identify the essential structural requirements in 3D chemical space for the modulation of the antimalarial activity of substituted 1,2,4 trioxanes. The superiority of Quantitative pharmacophore based alignment (QuantitativePBA) over global minima energy conformer-based alignment (GMCBA) has been reported in CoMFA and CoMSIA studies. The developed models showed good statistical significance in internal validation (q2, group cross-validation and bootstrapping) and performed very well in predicting antimalarial activity of test set compounds. Structural features in terms of their steric, electrostatic, and hydrophobic interactions in 3D space have been found important for the antimalarial activity of substituted 1,2,4-trioxanes. Further, the HQSAR studies based on the same training and test set acted as an additional tool to find the sub-structural fingerprints of substituted 1,2,4 trioxanes for their antimalarial activity. Together, these studies may facilitate the design and discovery of new substituted 1,2,4-trioxane with potent antimalarial activity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.03
- Field percentile
- top 23%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optimisation-based modelling for drug discovery in malaria
Yutong Li, Jonathan Cardoso‐Silva, … Sophia Tsoka·bioRxiv·Feb 12, 2022
- Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance
Matthew T. Klope, Poulami Talukder, … Adam R. Renslo·Science AdvancesPeer-reviewed·Aug 8, 2025
- A new in vitro checkerboard-parasite reduction ratio interaction assay for early de-risk of clinical development of antimalarial combinations
C. Demarta-Gatsi, S. Wicha, … M. Rottmann·bioRxiv·Apr 19, 2022
- Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as PfCDPK1 kinase inhibitors
- 3-Hydroxypropanamidines: from antiplasmodial leads to a novel antibacterial scaffold
Lara-Sophie Kaufmann, André Schultz, … Julia Elisabeth Bandow·bioRxiv·Sep 21, 2026
- Metabolomics reveals synergistic antimalarial drug pairing effects against Plasmodium falciparum in vitro
François Eya’ane Meva, Tarrick Qahash, … Manuel Llinás·bioRxiv·Dec 16, 2025